BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Treatment
35 results:

  • 1. Tumoricidal Activity of Simvastatin in Synergy with rhoa Inactivation in Antimigration of Clear Cell Renal Cell Carcinoma Cells.
    Lee YG; Chou FN; Tung SY; Chou HC; Ko TL; Fann YC; Juan SH
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298689
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Preclinical Evidence that Arctigenin Effectively and Selectively Targets Clear Cell Renal Cell Carcinoma Via Suppressing EGFR and rhoa.
    Liu D; Zhou G; Xu M
    Nutr Cancer; 2023; 75(5):1373-1381. PubMed ID: 36947006
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm.
    Tappero S; Barletta F; Piccinelli ML; Cano Garcia C; Incesu RB; Morra S; Scheipner L; Tian Z; Parodi S; Dell'Oglio P; Palumbo C; Briganti A; De Cobelli O; Chun FKH; Graefen M; Longo N; Ahyai S; Saad F; Shariat SF; Suardi N; Borghesi M; Terrone C; Karakiewicz PI
    Eur Urol Focus; 2023 Sep; 9(5):742-750. PubMed ID: 36906483
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pathological and Clinical Outcomes in a Large Surveillance and Intervention Cohort of Radiographically Cystic Renal Masses.
    Lee RA; Uzzo RG; Anaokar J; Thomas A; Wei S; Ristau BT; McIntosh A; Lee M; Chen DYT; Greenberg RE; Viterbo R; Smaldone MC; Correa A; Schober J; Ginsburg K; Bukavina L; Magee D; Uzzo N; Parkansky P; Ruth K; Kutikov A
    J Urol; 2023 Apr; 209(4):686-693. PubMed ID: 36630588
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical and economic burdens of recurrence following nephrectomy for intermediate high- or high-risk renal cell carcinoma: A retrospective analysis of Surveillance, Epidemiology, and End Results-Medicare data.
    Sundaram M; Song Y; Rogerio JW; Zhang S; Bhattacharya R; Adejoro O; Carley C; Zhu JJ; Signorovitch J; Haas NB
    J Manag Care Spec Pharm; 2022 Oct; 28(10):1149-1160. PubMed ID: 36048895
    [No Abstract]    [Full Text] [Related]  

  • 6. Construction and validation of a prognostic model for kidney renal clear cell carcinoma based on podocyte-associated genes.
    Chen C; Yang RX; Zhang JX; Xu HG
    Cancer Med; 2022 Oct; 11(19):3549-3562. PubMed ID: 35373928
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Ultrasound-Guided Renal Mass Biopsy and Its Clinical Utility: A Single-Centre Experience.
    Jasinski M; Siekiera J; Tworkiewicz M
    Urol Int; 2022; 106(6):560-566. PubMed ID: 35066507
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.
    Tian X; Xu WH; Wu JL; Gan HL; Wang HK; Gu WJ; Qu YY; Zhang HL; Ye DW
    Pathol Oncol Res; 2021; 27():1609809. PubMed ID: 34512202
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Yes-Associated Protein 1 Is a Novel Calcium Sensing Receptor Target in Human Parathyroid tumors.
    Tavanti GS; Verdelli C; Morotti A; Maroni P; Guarnieri V; Scillitani A; Silipigni R; Guerneri S; Maggiore R; Mari G; Vicentini L; Dalino Ciaramella P; Vaira V; Corbetta S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670622
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Recent Advances in Pathology: the 2020 Annual Review Issue of The Journal of Pathology.
    Herrington CS; Poulsom R; Coates PJ
    J Pathol; 2020 Apr; 250(5):475-479. PubMed ID: 32346919
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Application of multimode MRI in prediction of nuclear grade of clear cell renal cell carcinoma].
    Li Q; Liu ZH; Wang HY; Huang QB; Guo AT; Zhang XJ; Bai X; Ye HY
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(23):1767-1772. PubMed ID: 31207684
    [No Abstract]    [Full Text] [Related]  

  • 12. 'Full prosthetic jacket': external stenting of the renal vein.
    Dewulf M; Van Herzeele I; Decaestecker K; Vermassen F
    Acta Chir Belg; 2020 Oct; 120(5):357-360. PubMed ID: 30973079
    [No Abstract]    [Full Text] [Related]  

  • 13. Trifecta Outcomes in Renal Hilar tumors: A Comparison Between Robotic and Open Partial Nephrectomy.
    Sagalovich D; Dagenais J; Bertolo R; Garisto JD; Kaouk JH
    J Endourol; 2018 Sep; 32(9):831-836. PubMed ID: 29984597
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.
    Favazza L; Chitale DA; Barod R; Rogers CG; Kalyana-Sundaram S; Palanisamy N; Gupta NS; Williamson SR
    Mod Pathol; 2017 Nov; 30(11):1603-1612. PubMed ID: 28731045
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Everolimus suppresses invasion and migration of renal cell carcinoma by inhibiting FAK activity and reversing epithelial to mesenchymal transition in vitro and in vivo.
    Wu SW; Chen PN; Lin CY; Hsieh YS; Chang HR
    Environ Toxicol; 2017 Jul; 32(7):1888-1898. PubMed ID: 28258630
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies.
    Pircher A; Jöhrer K; Kocher F; Steiner N; Graziadei I; Heidegger I; Pichler R; Leonhartsberger N; Kremser C; Kern J; Untergasser G; Gunsilius E; Hilbe W
    Oncotarget; 2016 Apr; 7(15):20109-23. PubMed ID: 26956051
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer.
    Psutka SP; Boorjian SA; Moynagh MR; Schmit GD; Costello BA; Thompson RH; Stewart-Merrill SB; Lohse CM; Cheville JC; Leibovich BC; Tollefson MK
    J Urol; 2016 Feb; 195(2):270-6. PubMed ID: 26292038
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.
    Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H
    PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Abl Kinases Regulate HGF/Met Signaling Required for Epithelial Cell Scattering, Tubulogenesis and Motility.
    Li R; Knight JF; Park M; Pendergast AM
    PLoS One; 2015; 10(5):e0124960. PubMed ID: 25946048
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Audit of radiation dose delivered in time-resolved four-dimensional computed tomography in a radiotherapy department.
    Hubbard P; Callahan J; Cramb J; Budd R; Kron T
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):346-52. PubMed ID: 25728211
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.